RecallRadar

FDA Drug recall D-1413-2012

Daytrana (Methylphenidate) Transdermal System Patch, Delivers 20 mg over 9 hours (2. 2 mg/hr), 1 patch per pouch (NDC 68968-5554-01) packag…

On 2012-07-18 the FDA classified a Class II recall of Daytrana (Methylphenidate) Transdermal System Patch, Delivers 20 mg over 9 hours (2. 2 mg/hr), 1 patch per pouch (NDC 68968-5554-01) packag… by Noven Pharmaceuticals, citing miscalibrated/Defective Delivery System; exceeded the specification for both mechanical peel force (MPF) and/or the z-statistic value.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-1413-2012
ClassificationClass II
Statusterminated
Initiated2012-03-22
Published2012-07-18
Last updated2026-09-13 11:51 UTC
CompanyNoven Pharmaceuticals
DistributionUS

Product

Daytrana (Methylphenidate) Transdermal System Patch, Delivers 20 mg over 9 hours (2. 2 mg/hr), 1 patch per pouch (NDC 68968-5554-01) packaged in 3-count patches per box (NDC 68968-5554-3) , Rx only, Manufactured for Shire US Inc., Wayne, PA 19087 by Noven Pharmaceuticals, Inc., Miami, FL 33816.08/04/12.

Reason

Miscalibrated/Defective Delivery System; exceeded the specification for both mechanical peel force (MPF) and/or the z-statistic value

Identifiers

ndc68968-5552-3
ndc68968-5553-3
ndc68968-5554-3
ndc68968-5555-3
ndc68968-5554-01
code_infoLot # 53995

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1413-2012%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.